While MCG is undoubtedly valuable and essential in addressing the rising demand for early access to genetic testing for therapeutic purposes, our findings emphasize the necessity of referring all BRCA1/2 carriers to genetics specialists to fully realize the cancer prevention objective of genetic counselling itself. Here, BRCA1 is linked to cancer.